Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.
(Sharecast News) - Poolbeg Pharma revealed on Monday that chairman Cathal Friel had acquired 830,000 ordinary shares in the AIM-listed biopharmaceutical company.
Friel, who co-founded Poolbeg Pharma, purchased the shares at an average price of 11.68p each, for a total value of £96,944.
Following the transaction, Friel holds 37.21m ordinary Poolbeg shares, representing approximately 7.4% of the company's issued share capital.
As of 1620 GMT, Poolbeg shares were up 0.88% at 11.50p.
Reporting by Iain Gilbert at Sharecast.com
Top Director Buys
Poolbeg Pharma (POLB)
Director name: Friel,Cathal
Amount purchased: 830,000 @ 11.68p
Value: £96,944.00
Oryx International Growth Fund Ltd. (OIG)
Director name: Mills,Christopher
Amount purchased: 6,500 @ 1,147.30p
Value: £74,574.50
Oryx International Growth Fund Ltd. (OIG)
Director name: Mills,Christopher
Amount purchased: 4,500 @ 1,150.00p
Value: £51,750.00
Alphawave Ip Group (AWE)
Director name: Fonseca,Michelle Senecal de
Amount purchased: 25,284 @ 153.40p
Value: £38,785.66
(HWG)
Director name: Patmore,Katerina
Amount purchased: 114 @ 131.89p
Value: £150.35
(HWG)
Director name: Shillaw,Lynda
Amount purchased: 114 @ 131.89p
Value: £150.35
(HWG)
Director name: Birch,Chris
Amount purchased: 114 @ 131.89p
Value: £150.35
Xp Factory (XPF)
Director name: Harpham,Richard
Amount purchased: 939 @ 15.89p
Value: £149.21
Xp Factory (XPF)
Director name: Bird,Graham
Amount purchased: 939 @ 15.89p
Value: £149.21
Tesco (TSCO)
Director name: Murphy,Ken
Amount purchased: 49 @ 276.84p
Value: £135.65
Top Director Sells